{"id":"https://openalex.org/W2109925847","doi":"https://doi.org/10.1002/acr.20072","title":"Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study","display_name":"Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: Work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study","publication_year":2010,"publication_date":"2010-01-28","ids":{"openalex":"https://openalex.org/W2109925847","doi":"https://doi.org/10.1002/acr.20072","mag":"2109925847","pmid":"https://pubmed.ncbi.nlm.nih.gov/20191522"},"language":"en","primary_location":{"id":"doi:10.1002/acr.20072","doi":"https://doi.org/10.1002/acr.20072","is_oa":false,"landing_page_url":"https://doi.org/10.1002/acr.20072","pdf_url":null,"source":{"id":"https://openalex.org/S13698240","display_name":"Arthritis Care & Research","issn_l":"0893-7524","issn":["0893-7524","1529-0123","2151-464X","2151-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Care &amp; Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012009272","display_name":"Ronald van Vollenhoven","orcid":"https://orcid.org/0000-0001-6438-8663","observed_orcids":["https://orcid.org/0000-0001-6438-8663"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ronald F. van Vollenhoven","raw_affiliation_strings":["Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden","Dr. van Vollenhoven has received consultant fees, speaking fees, honoraria, and/or research grants (less than $10,000 each) from Abbott Pharmaceuticals, Bristol-Myers Squibb, Centocor, Roche, Wyeth, and Schering-Plough"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]},{"raw_affiliation_string":"Dr. van Vollenhoven has received consultant fees, speaking fees, honoraria, and/or research grants (less than $10,000 each) from Abbott Pharmaceuticals, Bristol-Myers Squibb, Centocor, Roche, Wyeth, and Schering-Plough","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109962019","display_name":"Mary A. Cifaldi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019813218","display_name":"Abbott (United Kingdom)","ror":"https://ror.org/03wnay029","country_code":"GB","type":"company","lineage":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4210126753","display_name":"Abbott (Germany)","ror":"https://ror.org/02x2gk324","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210088555","https://openalex.org/I4210126753"]}],"countries":["DE","GB","US"],"is_corresponding":true,"raw_author_name":"Mary A. Cifaldi","raw_affiliation_strings":["Drs. Cifaldi, Ray, and Chen own stock and/or hold stock options in Abbott Laboratories","Global Health Economics & Outcomes Research, Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drs. Cifaldi, Ray, and Chen own stock and/or hold stock options in Abbott Laboratories","institution_ids":["https://openalex.org/I3019813218","https://openalex.org/I4210126753"]},{"raw_affiliation_string":"Global Health Economics & Outcomes Research, Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Saurabh Ray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019813218","display_name":"Abbott (United Kingdom)","ror":"https://ror.org/03wnay029","country_code":"GB","type":"company","lineage":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4210126753","display_name":"Abbott (Germany)","ror":"https://ror.org/02x2gk324","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210088555","https://openalex.org/I4210126753"]}],"countries":["DE","GB","US"],"is_corresponding":false,"raw_author_name":"Saurabh Ray","raw_affiliation_strings":["Drs. Cifaldi, Ray, and Chen own stock and/or hold stock options in Abbott Laboratories","Global Health Economics & Outcomes Research, Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drs. Cifaldi, Ray, and Chen own stock and/or hold stock options in Abbott Laboratories","institution_ids":["https://openalex.org/I3019813218","https://openalex.org/I4210126753"]},{"raw_affiliation_string":"Global Health Economics & Outcomes Research, Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058365556","display_name":"Naijun Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019813218","display_name":"Abbott (United Kingdom)","ror":"https://ror.org/03wnay029","country_code":"GB","type":"company","lineage":["https://openalex.org/I3019813218","https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]},{"id":"https://openalex.org/I4210126753","display_name":"Abbott (Germany)","ror":"https://ror.org/02x2gk324","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210088555","https://openalex.org/I4210126753"]}],"countries":["DE","GB","US"],"is_corresponding":false,"raw_author_name":"Naijun Chen","raw_affiliation_strings":["Drs. Cifaldi, Ray, and Chen own stock and/or hold stock options in Abbott Laboratories","Global Health Economics & Outcomes Research, Abbott Laboratories, Abbott Park, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drs. Cifaldi, Ray, and Chen own stock and/or hold stock options in Abbott Laboratories","institution_ids":["https://openalex.org/I3019813218","https://openalex.org/I4210126753"]},{"raw_affiliation_string":"Global Health Economics & Outcomes Research, Abbott Laboratories, Abbott Park, Illinois","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030335777","display_name":"Michael H. Weisman","orcid":"https://orcid.org/0000-0001-5568-388X","observed_orcids":["https://orcid.org/0000-0001-5568-388X"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael H. Weisman","raw_affiliation_strings":["Cedars-Sinai Medical Center, Los Angeles, California","Dr. Weisman has received consultant fees (less than $10,000 each) from Abbott, Centocor, Genentech, Amgen, Rigel, Lilly, Biogen, UCB, and Roche, has served on the consulting/advisory/data safety monitoring boards for Amgen/Wyeth, ARRAY Biopharma, Crescendo Bioscience, Inc., Elan, Lilly, Merck & Co., Inc., Novartis, and UCB, and has received research grants from Abbott, Amgen, ARRAY Biopharma, Bristol-Myers Squibb, Centocor, Genentech, Human Genome Sciences, MedImmune, Novo Nordisk, Wyeth, XDx, Inc., and UCB"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Los Angeles, California","institution_ids":["https://openalex.org/I1282927834"]},{"raw_affiliation_string":"Dr. Weisman has received consultant fees (less than $10,000 each) from Abbott, Centocor, Genentech, Amgen, Rigel, Lilly, Biogen, UCB, and Roche, has served on the consulting/advisory/data safety monitoring boards for Amgen/Wyeth, ARRAY Biopharma, Crescendo Bioscience, Inc., Elan, Lilly, Merck & Co., Inc., Novartis, and UCB, and has received research grants from Abbott, Amgen, ARRAY Biopharma, Bristol-Myers Squibb, Centocor, Genentech, Human Genome Sciences, MedImmune, Novo Nordisk, Wyeth, XDx, Inc., and UCB","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5109962019"],"corresponding_institution_ids":["https://openalex.org/I3019813218","https://openalex.org/I4210088555","https://openalex.org/I4210126753"],"apc_list":{"value":4640,"currency":"USD","value_usd":4640},"apc_paid":null,"fwci":4.9884,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.95593132,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"62","issue":"2","first_page":"226","last_page":"234"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11084","display_name":"Workplace Health and Well-being","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/early-rheumatoid-arthritis","display_name":"early rheumatoid arthritis","score":0.8870000243186951},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9440000057220459},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/labor-productivity","display_name":"labor productivity","score":0.7649999856948853},{"id":"https://openalex.org/keywords/household-productivity","display_name":"household productivity","score":0.871999979019165},{"id":"https://openalex.org/keywords/absenteeism","display_name":"absenteeism","score":0.9549999833106995},{"id":"https://openalex.org/keywords/presenteeism","display_name":"presenteeism","score":1.0},{"id":"https://openalex.org/keywords/employment-status","display_name":"employment status","score":0.796999990940094},{"id":"https://openalex.org/keywords/radiographic-progression","display_name":"radiographic progression","score":0.8209999799728394},{"id":"https://openalex.org/keywords/premier-trial","display_name":"PREMIER trial","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.8160136938095093},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8067626953125},{"id":"https://openalex.org/C2779382274","wikidata":"https://www.wikidata.org/wiki/Q1756074","display_name":"Presenteeism","level":3,"score":0.7942386865615845},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6985859274864197},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6360917687416077},{"id":"https://openalex.org/C27400517","wikidata":"https://www.wikidata.org/wiki/Q332278","display_name":"Absenteeism","level":2,"score":0.5968510508537292},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.5833468437194824},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.565416157245636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5334650874137878},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5245423913002014},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5168629288673401},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.10869872570037842},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000041","descriptor_name":"Absenteeism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004526","descriptor_name":"Efficiency","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004651","descriptor_name":"Employment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005191","descriptor_name":"Family Characteristics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011859","descriptor_name":"Radiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017132","descriptor_name":"Workplace","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/acr.20072","doi":"https://doi.org/10.1002/acr.20072","is_oa":false,"landing_page_url":"https://doi.org/10.1002/acr.20072","pdf_url":null,"source":{"id":"https://openalex.org/S13698240","display_name":"Arthritis Care & Research","issn_l":"0893-7524","issn":["0893-7524","1529-0123","2151-464X","2151-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Care &amp; Research","raw_type":"journal-article"},{"id":"pmid:20191522","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20191522","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis care & research","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"},{"score":0.7257999777793884,"display_name":"Decent work and economic growth","id":"https://metadata.un.org/sdg/8"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306093","display_name":"Abbott Fund","ror":"https://ror.org/0052svj16"},{"id":"https://openalex.org/F4320306493","display_name":"Abbott Laboratories","ror":"https://ror.org/0052svj16"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W48703373","https://openalex.org/W97238271","https://openalex.org/W183402285","https://openalex.org/W1800491640","https://openalex.org/W1842666194","https://openalex.org/W1884756792","https://openalex.org/W1965176313","https://openalex.org/W1967026115","https://openalex.org/W1996389186","https://openalex.org/W1996437423","https://openalex.org/W1999777294","https://openalex.org/W2012536047","https://openalex.org/W2018627214","https://openalex.org/W2031988556","https://openalex.org/W2040253550","https://openalex.org/W2054070913","https://openalex.org/W2065419533","https://openalex.org/W2066409058","https://openalex.org/W2067437944","https://openalex.org/W2072599775","https://openalex.org/W2078317963","https://openalex.org/W2092195959","https://openalex.org/W2099885994","https://openalex.org/W2101223304","https://openalex.org/W2107769196","https://openalex.org/W2113509034","https://openalex.org/W2116843833","https://openalex.org/W2140731614","https://openalex.org/W2144230302","https://openalex.org/W2150819298","https://openalex.org/W2152348310","https://openalex.org/W2168711492","https://openalex.org/W2298627702","https://openalex.org/W2302652017","https://openalex.org/W2331151073","https://openalex.org/W2338178005","https://openalex.org/W2409499374","https://openalex.org/W2412802872"],"related_works":["https://openalex.org/W2342923384","https://openalex.org/W2284814126","https://openalex.org/W3012937015","https://openalex.org/W2331151073","https://openalex.org/W2072599775","https://openalex.org/W2334563230","https://openalex.org/W4411433352","https://openalex.org/W2555553338","https://openalex.org/W7222803129","https://openalex.org/W2181851399"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"household":[3,38,96],"and":[4,21,39,98,107,116,125,229],"work":[5,40,117,223],"place":[6,41,118],"outcomes":[7,119],"for":[8,123,151,158,166,182,205],"patients":[9,61,131,143],"with":[10,25,62,70,213,220],"rheumatoid":[11],"arthritis":[12],"(RA)":[13],"who":[14,22,67,132,144],"were":[15,23,45,101,120],"homemakers":[16,124],"or":[17,75,82,95,246],"employed":[18,126,152],"workers,":[19],"respectively,":[20],"treated":[24],"adalimumab":[26,71],"plus":[27,72],"methotrexate":[28,30,146,170,186,214],"versus":[29,148,155],"monotherapy.":[31,171],"We":[32],"also":[33],"determined":[34],"baseline":[35,106,238],"predictors":[36],"of":[37,59,79,88,91,174,232,241],"outcomes.":[42],"METHODS:":[43],"Data":[44],"from":[46,103],"a":[47,54],"health":[48],"economic":[49],"companion":[50],"study":[51],"to":[52,84,244],"PREMIER,":[53],"2-year,":[55],"randomized":[56],"controlled":[57],"trial":[58],"methotrexate-naive":[60],"early":[63],"RA":[64,92],"(<3":[65],"years)":[66],"received":[68,133,145],"treatment":[69],"methotrexate,":[73],"adalimumab,":[74],"methotrexate.":[76],"Absenteeism":[77],"(number":[78],"days":[80,141,150,157],"missed":[81,136],"unfit":[83],"work),":[85],"presenteeism":[86],"(self-judgment":[87],"the":[89,112,242],"effects":[90],"on":[93],"job":[94],"performance),":[97],"employment":[99,176,207],"status":[100],"collected":[102],"self-reports":[104],"at":[105,208,237],"varying":[108],"time":[109],"points":[110],"during":[111],"study.":[113],"RESULTS:":[114],"Household":[115],"generally":[121],"similar":[122],"workers.":[127],"Over":[128],"2":[129,178,209],"years,":[130],"combination":[134,167,183,216],"therapy":[135,168,184,217],"approximately":[137],"half":[138],"as":[139,142],"many":[140],"(17.4":[147],"36.9":[149],"workers;":[153],"7.9":[154],"18.6":[156],"homemakers).":[159],"Presenteeism":[160],"was":[161,180,201,218,239],"lower":[162],"(reflecting":[163],"better":[164],"productivity)":[165],"than":[169,185],"The":[172],"likelihood":[173,231],"gaining/retaining":[175,233],"over":[177],"years":[179],"greater":[181,230],"monotherapy":[187],"(odds":[188],"ratio":[189],"1.530,":[190],"95%":[191],"confidence":[192],"interval":[193],"1.038-2.255;":[194],"P":[195],"=":[196],"0.0318).":[197],"Baseline":[198],"radiographic":[199],"progression":[200,236],"an":[202],"independent":[203],"predictor":[204],"retaining/gaining":[206],"years.":[210],"CONCLUSION:":[211],"Compared":[212],"monotherapy,":[215],"associated":[219],"more":[221],"positive":[222],"outcomes:":[224],"less":[225,227],"absenteeism,":[226],"presenteeism,":[228],"employment.":[234,248],"Radiographic":[235],"predictive":[240],"ability":[243],"retain":[245],"gain":[247]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}